Cardiovascular risk profile of low-dose prednisolone and its effect on the quality of life in patients with adrenal insufficiency: the HYPER-AID observational study

Background: Patients with adrenal insufficiency require glucocorticoid replacement therapy either as hydrocortisone in multiple-daily doses or as low-dose prednisolone once daily. Data on the long-term safety, cardiovascular risk, and quality-of-life (QoL) outcomes of prednisolone remain limited. Me...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Emmanuel Ssemmondo, Katharine Lazarus, Milly Newham, Kavita Narula, Zin Htut, Thozhukat Sathyapalan, Sirazum Choudhury, Karim Meeran
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Bioscientifica 2026-02-01
Edice:	Endocrine Connections
Témata:	cardiovascular prednisolone hydrocortisone glucocorticoid replacement therapy
On-line přístup:	https://ec.bioscientifica.com/view/journals/ec/15/2/EC-25-0904.xml
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!